D'ALESSANDRO, Natale
D'ALESSANDRO, Natale
Scienze per la Promozione della Salute e Materno Infantile "G.D'Alessandro" (attivo dal 01/03/2008 al 31/12/2018)
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”.
2006-01-01 POMA P; NOTARBARTOLO DI VILLAROSA, M; LABBOZZETTA M; SANGUEDOLCE R; ALAIMO A; CARINA V; MAURICI A; CUSIMANO A; CERVELLO M; D'ALESSANDRO N
Aderenza alle linee guida sulla profilassi antibiotica delle infezioni della ferita chirurgica nel Policlinico Universitario "P. Giaccone" di Palermo
2014-01-01 Gagliano, M.; Carubia, L.; Torregrossa, M.; D'Alessandro, N
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers.
2012-01-01 Poma, P; Notarbartolo DI Villarosa, M; Labbozzetta, M; Vivona, N; D’Alessandro, N
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma
2009-01-01 Notarbartolo Di Villarosa, M; Labbozzetta, M; Poma, P; Florena, AM; Porcasi, R; Cervello, M; Giannitrapani, L; Montalto, G; D'Alessandro, N
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma
2010-01-01 Notarbartolo Di Villarosa, M; Giannitrapani, L; Poma, P; Labbozzetta, M; Florena, AM; Porcasi, R; Muggeo, VMR; Sandonato, L; D'Alessandro, N; Montalto, G
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma
2013-01-01 Poma, P; Notarbartolo Di Villarosa, M; Labbozzetta, M; Vivona, N; D'Alessandro, N
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma
2012-01-01 Poma, P; Labbozzetta, M; Vivona, N; Porcasi, R; D'Alessandro, N; Notarbartolo Di Villarosa, M
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil.
2013-01-01 Labbozzetta, M; Vivona, N; Poma, P; Notarbartolo Di Villarosa, M; D'Alessandro, N
Anticancer drugs and pharmacovigilance: the Sicilian regional program
2006-01-01 D'ALESSANDRO N; CAPUTI AP; CUTRONEO P; ALAIMO A; CAMPO S; BORSELLINO L
Antitumor activity of the novel small molecule Akt inhibitor SC66 in hepatocellular carcinoma cells.
2013-01-01 Cusimano, A; D’Alessandro, N; McCubrey, JA; Montalto, G; Cervello, M
Antitumor effects of curcumin and of its combination with cisplatin or doxorubicin on human hepatic cancer cells: possible relationship to NF-kB activation and IAP gene expression.
2004-01-01 NOTARBARTOLO M; P POMA; D PERRI; M CERVELLO; N DALESSANDRO
Antitumor effects of curcumin and of its combinations with cisplatin or doxorubicin on human hepatic cancer cells: Possible relationship to NF-kB activation and IAP gene expression
2004-01-01 M NOTARBARTOLO; P POMA; D PERRI; M CERVELLO; D'ALESSANDRO N
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells
2008-01-01 SIMONI, D; RIZZI, M; RONDANIN, R; BARUCHELLO, R; MARCHETTI, P; INVIDIATA, F; LABBOZZETTA, M; POMA, P; CARINA, V; NOTARBARTOLO DI VILLAROSA, M; ALAIMO, A; D'ALESSANDRO, N
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression.
2005-01-01 NOTARBARTOLO DI VILLAROSA M; P POMA; M LABBOZZETTA; A ALAIMO; M CERVELLO; N D'ALESSANDRO
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION
2005-01-01 NOTARBARTOLO DI VILLAROSA, M; POMA, P; PERRI, D; DUSONCHET, L; CERVELLO, M; D'ALESSANDRO, N
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production
2005-01-01 LABBOZZETTA M; CARINA V; NOTARBARTOLO M; POMA P; MAURICI A; CERVELLO M; D'ALESSANDRO N
Antitumor Effects of Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-kappa B Inhibitor, in Human Liver Cancer Cells Are Mediated through a Reactive Oxygen Species-Dependent Mechanism
2009-01-01 Lampiasi, N; Azzolina, A; D'Alessandro, N; Umezawa, K; McCubrey, JA; Montalto, G; Cervello, M
Antitumor effects of novel co-drugs linking histone deacetylase and ribonucleotide reductase inhibitors in hematological tumors
2011-01-01 Ferro, A; Cappellacci, L; Mingrino, A; Petrelli, R; Tolomeo, M; Vita, P; D'Alessandro, N; Dusonchet, L; Franchetti, P; Grifantini, M; Meli, M
Antitumor effects of the grape stilbenes resveratrol and piceatannol on multidrug and apoptosis resistant HL60 leukemia cells"
2005-01-01 PERRI D; ALAIMO A; NOTARBARTOLO M; LABBOZZETTA M; POMA P; CROSTA L; GRIPPI F; GEBBIA N; D'ALESSANDRO N
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production.
2005-01-01 NOTARBARTOLO M; LABBOZZETTA M; POMA P; CARINA V; ALAIMO A; MAURICI A; CERVELLO M; DALESSANDRO N